Ensysce Biosciences’ Newly Formulated Oxycodone Product Shows Resistance To Tampering, Abuse
Ensysce Biosciences Inc (NASDAQ:ENSC) announced topline results from a human abuse potential (HAP) study for PF614. PF614 is a new class…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.
Ensysce Biosciences Announces Initiation Of Second Human Abuse Potential Study, Being Conducted By Dr. Vince Clinical Research
~ Oral Opioid Abuse Being Explored for PF614 ~
~ Data From Trial Supports Abuse Deterrent Labeling, Designed to Measure the Potential for Drug Liking ~
SAN DIEGO, CA / ACCESSWIRE / September 22, 2022 / Ensysce
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.
